Back to search

Article

The safety and efficacy of nedaplatin and lobaplatin combined with pemetrexed in first-line chemotherapy for locally advanced and advanced lung adenocarcinoma - A retrospective study

2024-07-27

Abstract excerpt

<h4>Background: </h4> Due to the severe toxicity of carboplatin and cisplatin, nedaplatin and lobaplatin are increasingly used in advanced lung adenocarcinoma (LUAD). However, there are no studies comparing lobaplatin with nedaplatin in the treatment of advanced LUAD. In this study, patients with LUAD were treated with PN or PL, and the safety and efficacy of the two regimens were evaluated. <h4>Methods:</h4> A to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c60d8d2c-2486-5fa8-8ac4-8a7d2afb0c7c
DOI
10.22541/au.172209444.41046520/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The safety and efficacy of nedaplatin and lobaplatin combined with pemetrexed in first-line chemotherapy for locally advanced and advanced lung adenocarcinoma - A retrospective studyDOI 10.22541/au.172209444.41046520/v1
Comparison of efficacy and safety between PD-1 inhibitors and PD- L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysisSemantic proximity
Comparison of efficacy and safety of first-line treatment options for unresectable stage III non-small cell lung cancer: a retrospective analysisSemantic proximity
Chemotherapeutic Agents Increase PD-L1 Expression in A549 Lung Cancer Cell LineSemantic proximity
The Efficacy And Safety of Anlotinib Combined With Platinum-Etoposide Chemotherapy As First-Line Treatment For Extensive-Stage Small Cell Lung Cancer: A Chinese Multicenter Real-World StudySemantic proximity
Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-AnalysisSemantic proximity
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.Semantic proximity
Albumin Paclitaxel Plus Platinum With or Without Pembrolizumab for Metastatic Primary Pulmonary Lymphoepithelioma-like Carcinoma: a Retrospective Multicenter StudySemantic proximity
The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.Semantic proximity
A Phase I Dose-Escalation Study of Lobaplatin Combined with Paclitaxel in Platinum-Sensitive Recurrent Ovarian Epithelial Carcinoma: Safety, Tolerability, and Preliminary Efficacy AnalysisSemantic proximity
Sequentially administrated of pemetrexed with icotinib/erlotinib in lung adenocarcinoma cell lines in vitroSemantic proximity
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitors.Semantic proximity
Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: A single-center retrospective analysisSemantic proximity
Select a neighboring publication to make it the new centre.